A detailed history of Inverness Counsel LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Inverness Counsel LLC holds 842 shares of REGN stock, worth $710,311. This represents 0.03% of its overall portfolio holdings.

Number of Shares
842
Previous 784 7.4%
Holding current value
$710,311
Previous $463,000 25.27%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$573.97 - $724.32 $33,290 - $42,010
58 Added 7.4%
842 $580,000
Q2 2022

Jul 20, 2022

SELL
$548.35 - $738.84 $1,645 - $2,216
-3 Reduced 0.38%
784 $463,000
Q1 2022

May 05, 2022

BUY
$595.12 - $698.43 $238,643 - $280,070
401 Added 103.89%
787 $550,000
Q4 2021

Feb 07, 2022

SELL
$543.48 - $670.97 $96,739 - $119,432
-178 Reduced 31.56%
386 $244,000
Q3 2021

Nov 02, 2021

BUY
$574.03 - $680.96 $323,752 - $384,061
564 New
564 $341,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $90.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.